HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malini Olivo Selected Research

hypericin

9/2012Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer.
2/2012New frontier in hypericin-mediated diagnosis of cancer with current optical technologies.
9/2008Endoscopic image analysis of photosensitizer fluorescence as a promising noninvasive approach for pathological grading of bladder cancer in situ.
6/2008Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
12/2007Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
10/2007Effects of N-methyl pyrrolidone on the uptake of hypericin in human bladder carcinoma and co-staining with DAPI investigated by confocal microscopy.
10/2007Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
9/2007Fluorescence detection of bladder cancer using urine cytology.
3/2007Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model.
12/2006Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Malini Olivo Research Topics

Disease

73Neoplasms (Cancer)
12/2021 - 01/2002
18Urinary Bladder Neoplasms (Bladder Cancer)
12/2014 - 02/2003
14Carcinoma (Carcinomatosis)
09/2012 - 01/2002
12Nasopharyngeal Carcinoma
10/2007 - 03/2002
10Necrosis
05/2010 - 09/2002
7Hypoxia (Hypoxemia)
09/2011 - 12/2005
7Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2006 - 07/2002
6Phototoxic Dermatitis (Phototoxicity)
08/2008 - 09/2002
5Breast Neoplasms (Breast Cancer)
11/2021 - 02/2014
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2014 - 01/2002
3Hyperthermia
10/2021 - 01/2008
3Mouth Neoplasms (Oral Cancer)
07/2011 - 01/2002
3Hemangiosarcoma (Angiosarcoma)
08/2008 - 10/2007
3Photosensitivity Disorders (Photodermatitis)
12/2007 - 06/2002
2Atopic Dermatitis (Atopic Eczema)
06/2022 - 01/2019
2Wounds and Injuries (Trauma)
01/2021 - 01/2019
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 01/2015
2Ovarian Cysts (Ovarian Cyst)
01/2020 - 01/2019
2Glioblastoma (Glioblastoma Multiforme)
10/2018 - 01/2016
2Neoplasm Metastasis (Metastasis)
02/2015 - 05/2010
2Lung Neoplasms (Lung Cancer)
12/2007 - 03/2007
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
06/2021
1Vascular Diseases (Vascular Disease)
06/2021
1Margins of Excision
01/2021
1Eczema
04/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Ovarian Epithelial Carcinoma
01/2019
1Glioma (Gliomas)
10/2018
1Tuberculosis (Tuberculoses)
01/2018
1Influenza in Birds (Avian Flu)
10/2017
1Human Influenza (Influenza)
10/2017
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

361-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2014 - 03/2002
25hypericinIBA
09/2012 - 05/2002
24Photosensitizing Agents (Photosensitizers)IBA
02/2015 - 01/2002
16Pharmaceutical PreparationsIBA
10/2018 - 09/2002
11protoporphyrin IXIBA
01/2007 - 01/2002
9Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2014
8AcidsIBA
02/2015 - 01/2002
8phytochlorinIBA
10/2011 - 06/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011 - 12/2005
7Oxygen (Dioxygen)IBA
05/2010 - 01/2006
6Povidone (Crospovidone)IBA
01/2009 - 08/2006
5Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2002
4Contrast MediaIBA
02/2015 - 09/2009
4GoldIBA
01/2014 - 04/2009
4Messenger RNA (mRNA)IBA
09/2012 - 03/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2010 - 11/2003
4Angiogenesis InhibitorsIBA
11/2009 - 12/2005
4hypocrellin AIBA
01/2006 - 01/2002
3Hemoglobins (Hemoglobin)IBA
06/2021 - 10/2018
3LipidsIBA
09/2020 - 01/2002
3HaptoglobinsIBA
01/2020 - 01/2015
3Bevacizumab (Avastin)FDA Link
09/2011 - 12/2007
3chlorophyllin (copper chlorophyll)IBA
12/2010 - 08/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 10/2007
3CytokinesIBA
12/2007 - 07/2002
3N-methylpyrrolidoneIBA
10/2007 - 07/2006
3CaspasesIBA
03/2007 - 01/2002
3EstersIBA
10/2006 - 02/2003
3DNA (Deoxyribonucleic Acid)IBA
11/2005 - 01/2002
3hypocrellin BIBA
09/2004 - 01/2002
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2019 - 01/2007
2fosbretabulin (combretastatin A4)IBA
10/2018 - 10/2018
2PolymersIBA
01/2015 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
11/2014 - 11/2009
2Tumor Biomarkers (Tumor Markers)IBA
02/2014 - 03/2012
2SolutionsIBA
03/2012 - 08/2004
2Cetuximab (Erbitux)FDA Link
09/2011 - 11/2009
2chlorinIBA
01/2009 - 08/2006
2Angiogenic ProteinsIBA
06/2008 - 12/2007
2Celecoxib (Celebrex)FDA Link
10/2007 - 12/2005
2AlbuminsIBA
10/2007 - 03/2007
2SaltsIBA
11/2006 - 08/2006
2methylamphotericin B (AME)IBA
10/2006 - 02/2003
2PorphyrinsIBA
02/2003 - 11/2002
2Caspase 3 (Caspase-3)IBA
06/2002 - 03/2002
2Cytochromes c (Cytochrome c)IBA
06/2002 - 03/2002
1IntegrinsIBA
12/2021
1arginyl-glycyl-aspartic acidIBA
12/2021
1Circulating MicroRNAIBA
11/2021
1MicroRNAs (MicroRNA)IBA
11/2021
1Coloring Agents (Dyes)IBA
01/2021
1CelluloseIBA
01/2021
1Urocanic AcidIBA
04/2020
1CeramidesIBA
04/2020
1dupilumabIBA
01/2019
14-O-carboxymethylascochlorinIBA
10/2018
1Mycolic Acids (Mycolic Acid)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2016

Therapy/Procedure

31Photochemotherapy (Photodynamic Therapy)
09/2011 - 01/2002
13Therapeutics
10/2021 - 12/2005
12Lasers (Laser)
03/2017 - 03/2003
4Intravenous Administration
08/2008 - 11/2004
3Segmental Mastectomy (Lumpectomy)
01/2021 - 12/2018
2Photothermal Therapy
03/2017 - 02/2012
2Drug Therapy (Chemotherapy)
07/2009 - 12/2007
1Mastectomy (Mammectomy)
01/2021
1Micro-Electrical-Mechanical Systems
01/2019
1Solid-State Lasers
10/2018